Recent Headlines
Within Biotechnology
Three Top Colorado Bioscience CEOs Confirmed to Present at the 2014 BioWest Conference & Expo
Colorado BioScience Association (CBSA) will host three of Colorado’s top CEOs at the "Colorado Companies: From Concept to Market" panel presentation on September 10th at the 2014 BioWest Conference & Expo. Participating CEO’s include: Bill Aldrich, EndoShape; David Brunel, Biodesix; and Byron Hewett, SomaLogic. - August 30, 2014 - Colorado BioScience Association
Mac’s SET the PACE Race Superhero for a Day 5K Run/Walk
Join the Mac’s SET the PACE Race at Washington Park in Denver, CO. This event honors patients, survivors and their family members. Increasing awareness of prostate cancer and the importance of early detection with a fun day of activities for the whole family. - August 29, 2014 - Prostate Conditions Education Council
Pathology Diagnostics Ltd Contributes as Expert Advisor to Groundbreaking Medical Research Council (MRC) Review of UK Molecular Pathology Services
The MRC has recently published a thought provoking and comprehensive review of molecular pathology capabilities in the United Kingdom in R&D and healthcare. The UK government and research charities (TSB, MRC, NIHR, CRUK, Arthritis UK) are collectively investing £200 million in the field of molecular pathology via the Stratified Medicine Innovation Platform (SMIP). Pathology Diagnostics Ltd lent their expertise as expert advisors to the review. - August 29, 2014 - Pathology Diagnostics Ltd
MoBiTec, Germany, Announces Availability of Ebola Virus (EBOV) Real Time RT-PCR Kit
Ebola hemorrhagic fever (Ebola HF) is a severe, often fatal disease in humans and nonhuman primates, caused by infection with Ebolavirus. The recent Ebola outbreak in West Africa is one of the largest Ebola outbreaks in history. - August 28, 2014 - MoBiTec GmbH
NC COIN Promotes Karen Shank to Business Development Director
Pharma, Software, and Medical Technology Veteran Developing K-12 Programming, Expanding Membership Base of Nonprofit Idea Accelerator - August 27, 2014 - COIN
Creative Biomart Introduced Immobilized Enzyme Service
On August 24, 2014, Creative Biomart has introduced their novel service of immobilized enzymes. This novel service is based on a revolutionary new platform, combining affinity tag binding with inert porous materials, designed especially for biocatalysis application in any organic solvent or... - August 27, 2014 - Creative Biomart
Braasch Biotech to Participate at Informa's 9th Annual Veterinary Vaccine Conference
Braasch's Biotech's Dr. Keith Haffer to host seminar on adjuvants at Informa's Veterinary Vaccine Conference in December. - August 25, 2014 - Braasch Biotech LLC
MoBiTec GmbH to Attend Horizons in Molecular Biology Meeting in Goettingen, Germany, Sep 15-18, 2014
Horizons in Molecular Biology is an international symposium in the field of molecular life sciences, organized by PhD students of the MSc/PhD Molecular Biology Program - International Max Planck Research School (IMPRS). - August 24, 2014 - MoBiTec GmbH
Primerdesign Launch World’s Most Affordable DNA Testing System
Primerdesign Ltd is excited to announce the release of the World’s Most Affordable DNA Testing System. The genesig q16 accompanies a catalogue of over 400 easy to use DNA testing kits which encompass a range of practical applications. DNA testing is versatile and has a huge range of practical... - August 23, 2014 - Primerdesign Ltd
Cheers—Creative Biomart Launches High-Throughput Protein Production
The marketing chief staff of Creative Biomart has announced today that they will release the high-throughput protein production service on this very day in the aim of helping speed up their customer’s protein production project. Protein expression is widely used in the production of... - August 22, 2014 - Creative Biomart
Creative Biomart Launches Novel Service for Protein Labeling
On August 18, Creative Biomart had launched a novel service that is site-specific and custom labeling for protein labeling. This new service includes C-terminal labeling, N-terminal labeling, and Labeling at glycosylation sites. The launch of the site-specific and custom labeling service was said... - August 22, 2014 - Creative Biomart
Synpromics Announces Highly Successful Results from Plant Science Projects
Synpromics Limited, a privately held, Scottish-based synthetic biology company today announced that it has successfully generated several highly effective synthetic promoters for use in plants. - August 22, 2014 - Synpromics Ltd
Colorado BioScience Association Partners with PrIME Health Collaborative to Offer a BioWest 2014 Pre-Event
Colorado BioScience Association (CBSA) is partnering with the PrIME Health Collaborative (PrIME) to host the BioWest Pre-Event, the 2014 Digital Health Venture Showcase. The digital pre-event will be held the day before BioWest, September 9 (1 to 9 p.m.) at CSU Denver, 475 17th Street, 2nd Floor Atrium. Featuring a curated and vetted selection of pitches from the best and brightest Colorado digital health companies, finalists will vie for a share of $50,000 in prizes awarded by PrIME in partner. - August 22, 2014 - Colorado BioScience Association
Colorado BioScience Association Announces 2014 BioWest Venture Showcase Finalists
Colorado BioScience Association (CBSA) will hold its BioWest Conference, September 10, 2014, at the Marriott City Center, Denver. The three finalists in the 2014 Venture Showcase competition at BioWest include: dBMEDx, Littleton; KromaTiD, Inc., Fort Collins; Mighty Oak Medical, Englewood. - August 21, 2014 - Colorado BioScience Association
Creative Biomart Signed Industrial Enzymes Agreement
Creative Biomart signed an Industrial Enzymes Agreement with a UK Industrial giant (the name of the company is not allowed to be exposed according to the agreement). On the basis of this agreement, Creative Biomart is going to provide High-temperature Alpha-amylase for beer, Mid-temperature... - August 20, 2014 - Creative Biomart
Epitope Diagnostics, Inc. Introduces New 2-Hour Human ACTH ELISA Kit
Epitope Diagnostics releases a new, highly sensitive and robust human ACTH ELISA kit which can be completed in 2 hours, increasing the efficiency of clinical laboratory operations. - August 19, 2014 - Epitope Diagnostics, Inc.
MMS Holdings and Oncology Trials Insights Form Strategic Partnership to Deliver Comprehensive Oncology Support Services
MMS Holdings Inc., a global clinical research organization that focuses on regulatory submission support for the pharmaceutical, biotech and medical device industries, and Oncology Trials Insights (OTI), an organization of oncology key opinion leaders that architect superior clinical trial... - August 18, 2014 - MMS Holdings Inc.
Major Pipette Distributor Pipette.com Announces the Addition of the VistaLab Ovation M Pipette to Their Product Line
Pipette.com announces the inclusion of the Ovation M Pipette to their product portfolio, benefiting lab technicians looking for a truly ergonomic pipette. - August 16, 2014 - Pipette.com
Polmacoxib Demonstrates Prevention and Treatment Effects in Colorectal Cancer
CrystalGenomics, Inc., a clinical stage biopharmaceutical company headquartered in Korea, has reported a positive outcome from an investigational preclinical research conducted, in part, at the University of Texas MD Anderson Cancer Center by Dr. Raymond N. DuBois’ laboratory where the... - August 15, 2014 - CrystalGenomics, Inc.
Aquatrove Granted a US Patent on Its Proprietary Calcium and Magnesium Containing Fertility Lubricants
Aquatrove Biosciences, Inc granted a patent by the U.S.P.T.O for its Water-Based Personal Lubricants. - August 14, 2014 - Aquatrove Biosciences, Inc
Bioo Scientific First to Address Small RNA-Seq Bias Concerns with Launch of New Kit
Bioo Scientific's patent pending NEXTflex™ Small RNA Sequencing Kit v2 utilizes randomized adapters to significantly reduce ligation bias from library preparation, resulting in the most accurate data available. The NEXTflex Small RNA Sequencing Kit v2 provides an easy, flexible, cost-effective solution for generating small RNA libraries for sequencing on Illumina sequencing platforms. - August 14, 2014 - Bioo Scientific
Creative Diagnostics Expands Its Antibody Pairs Offering
By the time of the release, Creative Diagnostics has expanded its antibody pairs to over 40,000. - August 14, 2014 - Creative Diagnostics
New Pancreatic Cell Antibodies from ALPCO Allow Researchers to Identify and Isolate Major Pancreatic Cell Types
A new menu of pancreatic cell antibodies for the identification and isolation of major human pancreatic cell types is now available from ALPCO. - August 07, 2014 - ALPCO
BioGenex Opens European Office in Milan, Italy
A global market leader in fully-automated Molecular Pathology Systems, BioGenex, opens European office in Milan, Italy. - August 03, 2014 - BioGenex
Bioo Scientific Secures Patent for Using Type 1 Ribosome Inactivating Proteins as Therapeutic Agents
Bioo Scientific announced today that the U.S. Patent and Trademark Office (PTO) has issued Patent 8,715,676, “Production and Uses of Type 1 Ribosome Inactivating Proteins”, on May 6, 2014. The newly issued patent describes the use of recombinant type 1 ribosome inactivating proteins as... - August 03, 2014 - Bioo Scientific
BioGenex Launches New Website
A global market leader in fully-automated Molecular Pathology Systems, BioGenex, launches a new website for its customer’ worldwide. - August 03, 2014 - BioGenex
Weighing Boat Promotion Now Available at Pipette.com, Major Pipette Distributor
Pipette.com announces their new weighing boat promotion for August 2014. - August 01, 2014 - Pipette.com
Creative Diagnostics Expands Database of Antibody Pairs
The expanding of Creative Diagnostics' database of antibody pairs could largely save the preparation time of investigators. - August 01, 2014 - Creative Diagnostics
International Pipette Distributor, Pipette.com Announces the Addition of the Eppendorf Centrifuge 5427 R to Their Product Portfolio
Pipette.com is now offering the Eppendorf Centrifuge 5427 R as part of their centrifuge portfolio. The centrifuge is ideal for lab technicians working on high-end applications. - July 31, 2014 - Pipette.com
ALPCO Launches Antibodies Supporting Pancreatic Cancer Research
In response to recent reports that pancreatic cancer deaths are on the rise globally, ALPCO has released a line of pancreatic antibodies to provide the research community with reliable tools that can be used to better analyze and understand pancreatic cancer. - July 29, 2014 - ALPCO
CHI Announces Its 2nd Annual FAST: Functional Analysis & Screening Technologies Congress, November 17-19, 2014, Boston, MA
Keynote Presentations Delivered by George Church, Anna Collén, Meir Click and More - July 29, 2014 - Cambridge Healthtech Institute
DeoBioSciences to Launch Crowdfunding Campaign to Fund Revolutionary Cancer Research
DeoBioSciences, Inc. (”DBS” or “DeoBioSciences”) announced today that it is preparing to launch its Indiegogo.com crowdfunding campaign titled “Develop the World’s Most Powerful Weapon Against Cancer” (the “Campaign”) to raise funding for... - July 25, 2014 - DeoBioSciences, Inc.
MoBiTec, Germany, Announces Availability of Human Herpesvirus-6 (HHV-6) Assay Kits
Human herpesvirus (HHV-) 6 has been associated with various neurological diseases, including encephalitis, meningitis, epilepsy, and multiple sclerosis. MoBiTec partners with VIDIA, Czech Republic, to offer HHV-6 assay kits worldwide. - July 25, 2014 - MoBiTec GmbH
Creative Diagnostics Announces New Big Promotion Activity for Antibodies
Creative Diagnostics's July Big Promotion is open to customers around the world. - July 22, 2014 - Creative Diagnostics
Colorado BioScience Association Recognizes Amgen Foundation’s $25,000 Investment in STEM Education in Colorado’s Classrooms
Colorado BioScience Association (CBSA) is honored to announce the Amgen Foundation’s grant of $25,000 to the Colorado BioScience Institute (CBSI) in support of the Research Experience for Teachers (RET) program in Colorado’s science classrooms. The RET program is an intensive, 4 week, hands-on program in Science, Technology, Engineering and Mathematics (STEM) for 7th-12th grade teachers. - July 21, 2014 - Colorado BioScience Association
Bioo Scientific Launches 16S V1 – V3 rRNA Library Prep Kits for Bacterial Metagenomics Studies
Bioo Scientific’s NEXTflex™ 16S V1 – V3 Amplicon-Seq Kit simplifies bacterial metagenomics studies for sequencing on the Illumina® MiSeq platform. This kit allows users to go from sample to sequence in two hours, making it the fastest library prep kit available. Up to 384... - July 19, 2014 - Bioo Scientific
MoBiTec GmbH Teams Up with Protobios to Offer Epitope Mapping Service Using Mimotope Variation Analysis (MVA) Technology
MoBiTec, Germany, partners with the Estonian biotechnology company Protobios to offer Mimotope Variation Analysis (MVA)-based antibody epitope mapping service to scientists worldwide. - July 19, 2014 - MoBiTec GmbH
Case Study: Stem Cells vs Coronary Artery Bypass Surgery in a Patient with Multi-Vessel Disease 6 Year Follow Up
Stem cells outperform heart bypass surgery. A heart patient treated with his own stem cells instead of undergoing coronary bypass surgery is exceeding all expectations 6 years after his adult stem cell treatment. - July 17, 2014 - Regenocyte Worldwide
Pathology Diagnostics Ltd (PDL) Launches New Immunofluorescence Capabilities
Pathology Diagnostics has embraced the invaluably powerful technique of immunofluorescence (IMF); utilising fluorescent-labelled antibodies to detect specific target antigens. - July 11, 2014 - Pathology Diagnostics Ltd
Hormel Foods Specialty Products Division and VIRUN®, Granted Patent No. 8,741,373
VIRUN® and the Specialty Products Division at Hormel Foods were granted Patent number 8,741,373, Composition for Non-Polar Compounds. This particular patent allows unwavering high oil load encapsulation of non-polar compounds, such as Omega-3 EPA and DHA, CoQ10, Vitamins A, D, E, K, Carotenoids such as Lutein, Beta Carotene or Astaxanthin into certain water soluble and stable foods and beverages. - July 09, 2014 - VIRUN
Recursion Pharmaceuticals Announces Funding for Rett Syndrome Research
Recursion Pharmaceuticals has received support for focused work to identify a treatment for Rett Syndrome by the Rett Syndrome Research Trust. Recursion will apply its innovative drug discovery platform immediately to investigate the gene MECP2 in an effort to identify new therapeutics for the condition. - July 09, 2014 - Recursion Pharmaceuticals
Pathology Diagnostics Ltd.'s (PDL) Presence at Dako Symposium Strengthens Industry Connections
Senior technical management staff from Pathology Diagnostics attended the recent DakoLink-UP Scientific Symposium held in York in June 2014. Their presence strengthened connections already in place with Dako staff, and highlighted similarities in quality control and auditing needs with NHS... - July 05, 2014 - Pathology Diagnostics Ltd
Mirus Reagent Agent® Now on MoBiTec Website - Find the Appropriate Transfection Reagent for Your Cell Line and Experiment
MoBiTec GmbH, Germany, together with the transfection experts of Mirus Bio, USA, brings you the Reagent Agent® - a tool designed to determine the best solution for delivery of any nucleic acids into any cell type, including hard-to-transfect cell lines and primary cells. - July 05, 2014 - MoBiTec GmbH
Bioo Scientific Launches NEXTflex Cell Free DNA-Seq Kit Optimized for ctDNA and cfDNA Library Prep
The NEXTflex™ Cell Free DNA-Seq Kit for Illumina Library Preparation is optimized for library construction from low input amounts of circulating tumor DNA (ctDNA) or cell free fetal DNA (cffDNA). This is the first kit optimized specifically for library construction from DNA isolated from cell... - July 04, 2014 - Bioo Scientific
Colorado BioScience Association Welcomes the U.S. Patent and Trademark Office "Rocky Mountain Regional Satellite Office" to Denver
Colorado BioScience Association (CBSA) is honored to welcome the United States Patent and Trademark Office (USPTO) Rocky Mountain Regional Satellite Office to Denver. The office will be led by Russell Slifer, an intellectual property lawyer, who has served as chief patent counsel for Boise, Idaho-based Micron Technology for the past eight years. - June 30, 2014 - Colorado BioScience Association
Colorado BioScience Association Congratulates the Five Bioscience Companies Included in the "Colorado Companies to Watch" Class of 2014
Colorado BioScience Association Applauds the "Colorado Companies to Watch" program for honoring the contributions of five local bioscience companies to the state’s economy in its Class of 2014. Announced at a Gala held June 20th, the bioscience companies featured this year among the 50 honorees were: Eldon James Corp., JustRight Surgical LLC, MedKeeper, Sharklet Technologies and UrgentRx. - June 27, 2014 - Colorado BioScience Association
Pathology Diagnostics Ltd (PDL) Biomarker Test Portfolio and Advanced Staining Capabilities Show CAGR of 50%
Due to the recent rapid growth of Pathology Diagnostics Ltd (PDL), the advanced laboratory staining biomarker test portfolio of the organisation has grown at an extremely impressive rate, with the number of biomarkers validated now reaching over 370 for immunohistochemistry (IHC) and... - June 27, 2014 - Pathology Diagnostics Ltd
CrystalGenomics Receives KRW 13 Billion in Strategic Investment from the Global Pharmaceutical Industry Development Fund
CrystalGenomics, Inc., a late clinical stage biopharmaceutical company focused on developing and commercializing novel drugs for therapeutic areas of unmet medical needs, has just announced that it has received KRW 13 billion (USD 12.8 Million) from the Global Pharmaceutical Industry Development... - June 27, 2014 - CrystalGenomics, Inc.
Pipette.com Announces Sartorius mLINE Pipette Starter Kit Special
Pipette.com has announced their Sartorius mLINE Pipette Starter Kit Special which will benefit labs looking to mix and match sizes rather than have predetermined sizes. - June 26, 2014 - Pipette.com
AveXis Announces Dosing of First Patient for Gene Transfer Clinical Trial for Spinal Muscular Atrophy Type 1 at Nationwide Children’s Hospital
AveXis, Inc., a synthetic biology platform company, today announced that the first patient in the Gene Transfer Clinical Trial for Spinal Muscular Atrophy Type 1 has now been enrolled and dosed by Nationwide Children’s Hospital. This trial utilizes chariSMA, the gene therapy product developed... - June 26, 2014 - AveXis Inc.